KT-295

N/A

Report date: 2025/01/20 16:51:48
NME

Base Information

Drug NameKT-295
Drug Alias NameKT-295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 degraders
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPsoriasisInflammatory Bowel DiseasesArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKymera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKymera Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisInflammatory Bowel DiseasesArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A